Literature DB >> 21437726

Longitudinal change in cognitive function and medication adherence in HIV-infected adults.

Brian W Becker1, April D Thames, Ellen Woo, Steven A Castellon, Charles H Hinkin.   

Abstract

Neuropsychological (NP) dysfunction has been linked to poor medication adherence among HIV-infected adults. However, there is a dearth of research examining longitudinal changes in the relationship between NP status and adherence rates. We hypothesized that declines in NP functioning would be associated with a corresponding decline in medication adherence while stable NP functioning would be associated with stable or improving adherence rates. Participants included 215 HIV-infected adults who underwent cognitive testing at study entry and six months later. Compared to the NP stable group, the NP decline group showed a greater drop in adherence rates. Further analysis revealed that, beyond global NP, learning and memory was significantly associated with changes in adherence rates. These findings further support the link between cognitive functioning and medication adherence and illustrates the importance of documenting changes in cognitive abilities for identifying individuals at risk for poor adherence.

Entities:  

Mesh：

Year:  2011        PMID： 21437726      PMCID： PMC3616486          DOI： 10.1007/s10461-011-9924-z

Source DB:  PubMed          Journal:  AIDS Behav        ISSN： 1090-7165


  25 in total

1.  Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.

Authors:  P Richard Harrigan; Robert S Hogg; Winnie W Y Dong; Benita Yip; Brian Wynhoven; Justin Woodward; Chanson J Brumme; Zabrina L Brumme; Theresa Mo; Chris S Alexander; Julio S G Montaner
Journal:  J Infect Dis       Date:  2004-12-22       Impact factor: 5.226

2.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

Authors:  R L Spitzer; J B Williams; M Gibbon; M B First
Journal:  Arch Gen Psychiatry       Date:  1992-08

3.  Variations in patterns of highly active antiretroviral therapy (HAART) adherence.

Authors:  Andrew J Levine; Charles H Hinkin; Steven A Castellon; Karen I Mason; Mona N Lam; Adam Perkins; Marta Robinet; Douglas Longshore; Thomas Newton; Hector Myers; Ramani S Durvasula; David J Hardy
Journal:  AIDS Behav       Date:  2005-09

4.  Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status.

Authors:  Terry R Barclay; Charles H Hinkin; Steven A Castellon; Karen I Mason; Matthew J Reinhard; Sarah D Marion; Andrew J Levine; Ramani S Durvasula
Journal:  Health Psychol       Date:  2007-01       Impact factor: 4.267

5.  Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS)

Authors:  E N Miller; O A Selnes; J C McArthur; P Satz; J T Becker; B A Cohen; K Sheridan; A M Machado; W G Van Gorp; B Visscher
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

6.  The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

Authors:  R K Heaton; I Grant; N Butters; D A White; D Kirson; J H Atkinson; J A McCutchan; M J Taylor; M D Kelly; R J Ellis
Journal:  J Int Neuropsychol Soc       Date:  1995-05       Impact factor: 2.892

7.  Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients.

Authors:  J L Casado; R Sabido; M J Perez-Elías; A Antela; J Oliva; F Dronda; B Mejía; J Fortún
Journal:  Antivir Ther       Date:  1999

8.  Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.

Authors:  Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

9.  The projected incidence of AIDS and estimated prevalence of HIV infection in the United States.

Authors:  J M Karon; T J Dondero; J W Curran
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988

10.  Neuropsychological performance in symptomatic and asymptomatic HIV infection.

Authors:  R A Bornstein; H A Nasrallah; M F Para; C C Whitacre; P Rosenberger; R J Fass
Journal:  AIDS       Date:  1993-04       Impact factor: 4.177
View more
  59 in total

1.  Combined effects of HIV and marijuana use on neurocognitive functioning and immune status.

Authors:  April D Thames; Zanjbeel Mahmood; Alison C Burggren; Ahoo Karimian; Taylor P Kuhn
Journal:  AIDS Care       Date:  2015-12-23

2.  The role of neuroplasticity and cognitive reserve in aging with HIV: recommendations for cognitive protection and rehabilitation.

Authors:  David E Vance; Pariya L Fazeli; Joan S Grant; Larry Z Slater; James L Raper
Journal:  J Neurosci Nurs       Date:  2013-10       Impact factor: 1.230

3.  Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.

Authors:  Roman Shrestha; Frederick L Altice; Brian Sibilio; Jude Ssenyonjo; Michael M Copenhaver
Journal:  Contemp Clin Trials       Date:  2019-06-20       Impact factor: 2.226

4.  Psychosocial Correlates of Medication Adherence among HIV-Positive, Cognitively Impaired Individuals.

Authors:  Timothy J Arentsen; Stella Panos; April D Thames; J Natalie Arbid; Steven A Castellon; Charles H Hinkin
Journal:  J HIV AIDS Soc Serv       Date:  2016-09-23

5.  Modeling a Theory-Based Approach to Examine the Influence of Neurocognitive Impairment on HIV Risk Reduction Behaviors Among Drug Users in Treatment.

Authors:  Tania B Huedo-Medina; Roman Shrestha; Michael Copenhaver
Journal:  AIDS Behav       Date:  2016-08

6.  Neurocognitive Impairment Risk Among Individuals With Multiple Drug-Resistant Tuberculosis and Human Immunodeficiency Virus Coinfection: Implications for Systematic Linkage to and Retention of Care in Tuberculosis/Human Immunodeficiency Virus Treatment.

Authors:  Andrew Tomita; Suvira Ramlall; Thirusha Naidu; Sbusisiwe Sandra Mthembu; Nesri Padayatchi; Jonathan K Burns
Journal:  J Nerv Ment Dis       Date:  2019-04       Impact factor: 2.254

7.  Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infection.

Authors:  Sharon L Nichols; Grace Montepiedra; John J Farley; Patricia A Sirois; Kathleen Malee; Betsy Kammerer; Patricia A Garvie; Sylvie Naar-King
Journal:  J Dev Behav Pediatr       Date:  2012-05       Impact factor: 2.225

8.  Quality of life among South African patients receiving antiretroviral therapy in the Western Cape Province.

Authors:  Ashraf Kagee; Bronwynè Coetzee; Henry Steel
Journal:  S Afr J Psychol       Date:  2016-01-11

9.  Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence.

Authors:  Albert M Anderson; Melinda K Higgins; Raymond L Ownby; Drenna Waldrop-Valverde
Journal:  AIDS Care       Date:  2014-12-06

10.  Neurocognitive Functioning is Associated with Self-Reported and Performance-Based Treatment Management Abilities in People Living with HIV with Low Health Literacy.

Authors:  Pariya L Fazeli; Steven Paul Woods; Crystal Chapman Lambert; Drenna Waldrop-Valverde; David E Vance
Journal:  Arch Clin Neuropsychol       Date:  2020-07-24       Impact factor: 2.813
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.